S100B Mini-Promoters for Specific Brain Cell Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for promoter elements that can drive specific expression in certain cell types and regions of the brain, as existing S100B promoters are complex and require identification of minimal elements for adequate and specific expression.
Innovation Solution
The development of novel S100B mini-promoters comprising an S100B regulatory element operably linked in a non-native conformation to an S100B basal promoter, which are capable of directing transcriptional expression in specific cell types and brain regions, utilizing sequences substantially similar to SEQ ID NO: 1, 2, and 3, and linked to expressible sequences such as reporter genes or therapeutic proteins.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If native S100B promoter sequences are used, then cell-specific expression in brain regions is achieved, but promoter complexity and length increase
Solution Approach 1:
The patent extracts only the essential regulatory elements (minimal promoter region) from the complete native S100B promoter sequence. By identifying and isolating the critical transcription factor binding sites and core promoter elements required for cell-specific expression, the invention creates a truncated mini-promoter that maintains functional specificity while eliminating redundant sequences, thus reducing overall complexity.
Solution Approach 2:
The patent segments the native promoter into distinct functional modules: a minimal core promoter region containing essential TATA box and initiator elements, and specific regulatory elements with transcription factor binding sites. This segmentation allows selective combination of promoter components to achieve desired expression patterns with reduced complexity compared to using the entire native promoter.
2Reliability
If complete S100B promoter region is used, then adequate expression is achieved, but ease of use in expression constructs decreases
Solution Approach 1:
The invention extracts the minimal functional promoter region required for adequate expression from the complete S100B promoter. By removing non-essential upstream and downstream sequences while retaining core promoter elements and critical regulatory sites, the resulting mini-promoter is more compact and easier to clone into expression vectors, improving ease of use without compromising expression adequacy.
3Reliability
If native promoter configuration is used, then natural regulation is maintained, but adaptability for non-native applications is reduced
Solution Approach 1:
The patent segments the native promoter into modular functional elements that can be independently manipulated and recombined. This modular design allows the regulatory elements to be adapted for non-native applications, such as driving expression of transgenic genes or fusion proteins, while maintaining the core regulatory logic that ensures reliable cell-specific expression patterns.
Solution Approach 2:
The invention modifies promoter parameters by altering sequence length, removing non-essential regions, and optimizing the arrangement of regulatory elements. These parameter changes enhance adaptability for various biotechnological applications while preserving the fundamental regulatory mechanisms that confer cell-specific expression fidelity.
Data Source
AI summary
Isolated polynucleotides comprising an S100B promoter are provided, where an S100B regulatory element is operably joined to an S100B basal promoter utilizing a non-native spacing between the promoter and regulatory elements. The promoter may be operably linked to an expressible sequence, e.g. reporter genes, genes encoding a polypeptide of interest, regulatory RNA sequences such as miRNA, siRNA, anti-sense RNA, etc., and the like. In some embodiments a cell comprising a stable integrant of an expression vector is provided, which may be integrated in the genome of the cell. The promoter may also be provided in a vector, for example in combination with an expressible sequence. The polynucleotides find use in a method of expressing a sequence of interest, e.g. for identifying or labeling cells, monitoring or tracking the expression of cells, etc.